Figure 7.
P-curves of findings showing vigilance for negative information from studies with clinical populations. Within-subjects effects were given priority for inclusion in the p-curve on the left (A), followed by between-subjects effects, followed by correlations. For the p-curve on the right (B), between-subjects effects were given priority, followed by within-subjects effects, followed by correlations. Note. Blue line represents distribution of p-values.